Medication info

Lacunin Tablet (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Keeps Biopharma Co., Ltd.
Appearance
Light yellow to pale yellow round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201903631 · Approved 2019.05.31

This product's status changed to Expired on 2024.05.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
1. Adults Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, and in conditions caused by nonsteroidal anti-inflammatory drugs, usually within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg of this medicine 3 times daily and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment In patients with severe renal impairment and a creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
For patients aged 8 〜 18 years, 150 mg (2 mg per kg of body weight) may be administered up to twice daily. For patients aged 12 years and older, administer 75 mg of this medicine orally twice daily (liquid formulation only).

Ingredients

Manufacturer
Keeps Biopharma Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson’s syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers due to NSAID use
  • gastric mucosal lesions
  • erosions
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used to treat diseases caused by excessive gastric acid such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps to prevent Mendelson’s syndrome during anesthesia before surgery and plays a role in preventing ulcers that may occur after surgery. It is effective in treating gastric and duodenal ulcers due to non-steroidal anti-inflammatory drug use. It also aids in the improvement of lesions such as erosions or bleeding in acute and chronic gastritis. Additionally, it alleviates symptoms like heartburn and regurgitation, thus reducing discomfort for patients. Overall, it is used for the treatment and symptom relief of various gastrointestinal diseases related to excessive gastric acid.

How to take

Adult dose

1. Adults Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, and in conditions caused by nonsteroidal anti-inflammatory drugs, usually within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg of this medicine 3 times daily and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment In patients with severe renal impairment and a creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

For patients aged 8 〜 18 years, 150 mg (2 mg per kg of body weight) may be administered up to twice daily. For patients aged 12 years and older, administer 75 mg of this medicine orally twice daily (liquid formulation only).

Precautions

This medication should not be used in certain patients. For example, individuals who have had allergic reactions to this medication or its ingredients should not take it. Patients with a history of acute porphyria, a rare disease, should not be administered this medication as it may trigger seizures. This medication contains lactose, so patients with genetic lactose intolerance or related diseases should not take it. In patients with impaired kidney function, this medication is excreted through the kidneys, which may cause an increase in blood concentration, thus requiring dose adjustment. Patients with impaired liver function should also use this medication carefully, and those with a history of drug allergies or elderly patients should be cautious as well. Patients taking non-steroidal anti-inflammatory drugs, especially elderly patients or those with a history of gastric ulcers, need regular monitoring. This medication can mask symptoms of gastric cancer; therefore, gastric ulcer patients or newly developed or changed dyspeptic symptoms in middle-aged and older patients should verify the presence of malignant disease before administration. Gastric and duodenal ulcer patients that test positive for Helicobacter pylori require eradication therapy. This medication may rarely cause severe allergic reactions such as anaphylactic shock; if unusual symptoms occur, administration should be stopped immediately, and appropriate treatment should be sought. If symptoms such as hives, rash, difficulty breathing, or hypotension occur, discontinuation is necessary. There may be abnormalities detected in blood tests; therefore, if symptoms such as general malaise, bleeding, or fever arise, the physician should be informed immediately. If liver function abnormalities occur, administration should be suspended if the liver function test results are abnormal. There may be rare occurrences of arrhythmias or vasculitis, so caution is advised if such symptoms appear. Gastrointestinal symptoms may include constipation, nausea, abdominal pain; however, diarrhea or acute pancreatitis may occur infrequently. Neurological side effects such as dizziness, drowsiness, headache, or confusion may occur, thus medical consultation is necessary if unusual symptoms arise. Gynecomastia or changes in sexual function have been reported rarely, but causation is unclear. Myalgia or arthralgia may occur, and rarely muscle damage can develop, so caution is advised. Skin rashes or hair loss may occur infrequently. During the course of this treatment, blood, liver, and kidney function tests should be periodically performed to monitor therapeutic effects. Elderly or chronic disease patients have an increased risk of pneumonia, hence caution is needed. If dizziness or drowsiness occurs while taking this medication, driving or operating dangerous machinery should be avoided. There may be potential interactions with other medications; therefore, it is necessary to consult with a doctor or pharmacist if taking other medications. Pregnant women, women who could become pregnant, and breastfeeding women should carefully consider the risks and benefits before taking this medication. Safety in children has not been sufficiently established, hence caution is needed for use. No specific severe problems have been reported in cases of overdose; however, vomiting or gastric lavage or other appropriate treatment may be required. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 58 more
  • leukopenia
  • thrombocytopenia
  • bone marrow hypoplasia
  • aplastic anemia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • transient liver function abnormalities
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distention
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness in the head
  • insomnia
  • excitement
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hypertonic muscle cramps
  • gynecomastia
  • hypersecretion of milk
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that blocks light and air, maintaining a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help to preserve the efficacy and safety of the medication.

Appearance and packaging

Appearance

Light yellow to pale yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.